Examon Products & Services Mission References Contact EXAMON TURKEY YÖNETİM DANIŞMANLIĞI ANONİM ŞİRKETİ This is Examon new strategy to look for investment opportunities in the financial instruments, especially in emerging markets. Turkey with a remarkable rate of growth after 1980’s became 17th largest economy in the world and 6th largest economy compared with EU countries in 2017. Robust economic growth with an average annual real GDP growth of 5.6 percent during 2003-2016 and achieving GDP of USD 849,48 billion in 2017, up from USD 236 billion in 2002 were consequences of the following economic reforms: Economy liberalization and shifting from agriculture towards industrial and service activities; Modernization of the existing industries and technology transfer; Facilitating international trade and absorbing foreign investments and Sound economic policies with a prudent fiscal discipline and strong financial structure resilient to the global financial crisis. EXAMON TURKEY YÖNETİM DANIŞMANLIĞI ANONİM ŞİRKETİ will primarily focus on investing in the financial instruments registered in Istanbul Stock Exchange such as shares, derivatives, mutual funds, governmental bonds, etc. for the sole purpose of utilizing the available Examon funds for gaining financial returns. In further steps, our Turkish establishment will work on other business opportunities such as exporting Turkish manufacturing products to EU and Middle East. Datenschutz Impressum

Examon Products & Services Mission References Contact EXAMON is proud to have gained the trust of many international partners in the pharmaceutical industry which include the following companies: Astellas Biosyent Biotest B.Braun Engelhard Arzneimittel Fresenius Kabi Merck Nestrade (a Nestlé Company) Leo Pharma PTC Therapeutics Sanofi Genzyme Servier Datenschutz Impressum